![CASI Pharmaceuticals, Inc. logo](/logos/CASI.webp)
CASI Pharmaceuticals, Inc.
NASDAQ:CASI
Overview | Financials
Company Name | CASI Pharmaceuticals, Inc. |
Symbol | CASI |
Currency | USD |
Price | 6.5 |
Market Cap | 87,109,100 |
Dividend Yield | 0% |
52-week-range | 1.9 - 8.48 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Wei-Wu He Ph.D. |
Website | https://www.casipharmaceuticals.com |
An error occurred while fetching data.
About CASI Pharmaceuticals, Inc.
CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patients with multiple myeloma. The
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD